BioSTL, a St. Louis-based health innovation booster, announced plans to launch a new center designed to advance technologies to support the military. The Center for Defense Medicine will use BioSTL’s investment arm, BioGenerator, to focus on helping St. Louis-based startups develop and advance products and technology that can be used by U.S. military personnel.
“BioSTL has quietly grown its footprint in defense medicine with our staff expending considerable time and resources to understand the processes and medical demands of defense agencies,” said Eric Gulve, President of BioGenerator. “Concentrating and expanding this effort through the Center for Defense Medicine will unlock new startup activity and economic opportunity for St. Louis.”
BioSTL said it worked with experts from the defense industry to identify Missouri’s research strengths and strategize on how it can advance defense medicine technologies at the St. Louis center. BioSTL said it will use the funds to boost the region’s focus on defense medicine by assisting to launch new technologies and companies, helping grow and fund startups, facilitating relationships between entrepreneurs and government officials, and supporting startups in their efforts to win federal, non-dilutive grants and contracts.